Activest Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.06M Buy
2,647
+74
+3% +$87.3K 0.57% 26
2026
Q2
$3.09M Sell
2,573
-66
-3% -$67.4K 0.6% 23
2026
Q1
$2.43M Buy
2,639
+2,043
+343% +$2.07M 0.43% 31
2025
Q4
$640K Buy
596
+103
+21% +$98.5K 0.12% 78
2025
Q3
$376K Buy
493
+301
+157% +$224K 0.08% 90
2025
Q2
$150K Sell
192
-38
-17% -$29.5K 0.04% 110
2025
Q1
$190K Buy
230
+116
+102% +$96.5K 0.05% 100
2024
Q4
$87.9K Sell
114
-2
-2% -$1.66K 0.02% 132
2024
Q3
$103K Buy
116
+66
+132% +$59.3K 0.03% 119
2024
Q2
$45.3K Hold
50
– – 0.01% 179
2024
Q1
$38.9K Buy
+50
New +$35.6K 0.02% 131
2023
Q3
– Sell
-88
Closed -$45.3K – 368
2023
Q2
$39.9K Buy
+88
New +$36.9K 0.03% 97

Other funds holding LLY

Activest Wealth Management's LLY Position: Q3 2026 in Review

Activest Wealth Management increased its Eli Lilly (LLY) stake by 2.9% in Q3 2026, buying an estimated $87.3K and bringing the position to 2,647 shares worth $3.06M. The position accounts for 0.57% of the portfolio, ranked #26.

Activest Wealth Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.09M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Activest Wealth Management held 2,647 shares of Eli Lilly worth $3.06M as of Q3 2026.
  • Activest Wealth Management bought 74 Eli Lilly shares in Q3 2026, an estimated $87.3K.
  • Eli Lilly made up 0.57% of Activest Wealth Management's portfolio in Q3 2026, its #26 holding.
  • Activest Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Activest Wealth Management's Eli Lilly position peaked at $3.09M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.